Mondaq All Regions - Poland: Food, Drugs, Healthcare, Life Sciences
Czyzewscy Kancelaria Adwokacka
The act will come into force 30 days after its publication in the Journal of Laws.
Schoenherr Attorneys at Law
On 15 May 2017 the President of Poland executed the Act of 7 April 2017 amending the Pharmaceutical Law (the "Amending Act"), which changes the current regulations of the Act of 6 September 2001 Pharmaceutical Law ..
Global Advertising Lawyers Alliance (GALA)
The pharmaceutical market in Poland has significantly developed during the last decades making it attractive for investors.
CMS Cameron McKenna LLP
Products which are not registered as medicines may not be advertised as having medicinal properties, according to a decision of the Chief Pharmaceutical Inspector.
CMS Cameron McKenna LLP
From 1 January 2012, doctors will only be able to obtain a medicinal product sample for 2 years after first requesting it, and will be limited to a maximum of 4 samples per year.
CMS Cameron McKenna LLP
New laws governing the reimbursement of medicines, medical devices and foodstuffs for special medical purposes have been signed by the President.
CMS Cameron McKenna LLP
The Polish Parliament adopted a new law governing the reimbursement of medicinal products, medical devices and food for special medical purposes.
CMS Cameron McKenna LLP
Changes may be made to the way clinical trials are financed, supervised and conducted following an inspection of 13 clinical hospitals by the Supreme Audit Office (NIK).
CMS Cameron McKenna LLP
The Chief Pharmaceutical Inspector is entitled to supervise all pharmaceutical trade in Poland, including trade by companies based outside Poland, according to the Voivodship Administrative Court in Warsaw.
CMS Cameron McKenna LLP
Significant proposed changes to pharmaceutical advertising are included in the ‘health pack’ currently being considered in Parliament.
CMS Cameron McKenna LLP
The data exclusivity period applicable to pharmaceuticals for human use is to be extended by the introduction of an 8+2+1 rule to replace the current 6-year exclusivity period.
CMS Cameron McKenna LLP
The procedures for setting prices and applying for reimbursement of pharmaceuticals and medical devices is to be fundamentally changed.
CMS Cameron McKenna LLP
From 4 June 2010, new rules apply to the composition and labeling of dietary supplements.
CMS Cameron McKenna LLP
From 22 March 2010, the period for which sponsors must keep basic documentation of a clinical trial will be extended from two to five years.
CMS Cameron McKenna LLP
Foodstuffs such as dietary supplements may be subject to amended procedure where there are concerns whether they meet the criteria for medicinal products.
CMS Cameron McKenna LLP
The interim period for borderline products will expire on 31 December 2009 after attempts to extend it failed.
Most Popular Recent Articles
Czyzewscy Kancelaria Adwokacka
The act will come into force 30 days after its publication in the Journal of Laws.
Schoenherr Attorneys at Law
On 15 May 2017 the President of Poland executed the Act of 7 April 2017 amending the Pharmaceutical Law (the "Amending Act"), which changes the current regulations of the Act of 6 September 2001 Pharmaceutical Law ..
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter